Tranche Update on Sakai Chemical Industry Co., Ltd.'s Equity Buyback Plan announced on July 23, 2018.
December 21, 2018 at 01:00 am
Share
From October 1, 2018 to December 20, 2018, the company has repurchased 432,600 shares, representing 2.51% for ¥1,156.11 million. With this, the company has completed the repurchase of 724,400 shares, representing 4.18% for ¥1,999.79 million under the buyback announced on July 23, 2018.
SAKAI CHEMICAL INDUSTRY CO., LTD. is a Japan-based company principally manufactures and sells chemical industry products. The Company operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.
SAKAI CHEMICAL INDUSTRY CO., LTD. 
